AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹3,266 Cr | ₹2,739 Cr | ₹4,496 Cr | ₹2,938 Cr | ₹2,429 Cr |
What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹3,266 Cr |
| Mar2024 | ₹2,739 Cr |
| Mar2023 | ₹4,496 Cr |
| Mar2022 | ₹2,938 Cr |
| Mar2021 | ₹2,429 Cr |
How is Capital Work in Progress of AUROBINDO PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,266 Cr | 19.22 | |
| Mar2024 | ₹2,739 Cr | -39.08 | |
| Mar2023 | ₹4,496 Cr | 53.07 | |
| Mar2022 | ₹2,938 Cr | 20.94 | |
| Mar2021 | ₹2,429 Cr | - | |
Compare Capital Work in Progress of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹79,906.5 Cr | -3% | 5.6% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -3% |
5.6% |
11.5% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses